Literature DB >> 27097929

The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia.

Harinder Gill1, Garret M K Leung1, David Lopes2, Yok-Lam Kwong1.   

Abstract

Entities:  

Keywords:  aplastic anaemia; eltrombopag; romiplostim; treatment

Mesh:

Substances:

Year:  2016        PMID: 27097929     DOI: 10.1111/bjh.14024

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  14 in total

Review 1.  Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice.

Authors:  Cindy E Neunert; Melissa J Rose
Journal:  Blood Adv       Date:  2019-06-25

Review 2.  Activity of eltrombopag in severe aplastic anemia.

Authors:  Phillip Scheinberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 3.  Activity of eltrombopag in severe aplastic anemia.

Authors:  Phillip Scheinberg
Journal:  Blood Adv       Date:  2018-11-13

Review 4.  From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.

Authors:  Harinder Gill; Raymond S M Wong; Yok-Lam Kwong
Journal:  Ther Adv Hematol       Date:  2017-02-01

5.  A Novel Combination Therapy of Erythropoietin and Thrombopoietin to Treat Erythropoietin-Resistance anemia.

Authors:  Huixi Zou; Peng Xu; Raymond S M Wong; Xiaoyu Yan
Journal:  Pharm Res       Date:  2022-06-03       Impact factor: 4.200

6.  Efficacy and Safety of Eltrombopag for Aplastic Anemia: A Systematic Review and Meta-analysis.

Authors:  Yaqun Hong; Xiaofan Li; Bo Wan; Nainong Li; Yuanzhong Chen
Journal:  Clin Drug Investig       Date:  2019-02       Impact factor: 3.580

7.  Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia.

Authors:  Etienne Lengline; Bernard Drenou; Pierre Peterlin; Olivier Tournilhac; Julie Abraham; Ana Berceanu; Brigitte Dupriez; Gaelle Guillerm; Emmanuel Raffoux; Flore Sicre de Fontbrune; Lionel Ades; Marie Balsat; Driss Chaoui; Paul Coppo; Selim Corm; Thierry Leblanc; Natacha Maillard; Louis Terriou; Gerard Socié; Regis Peffault de Latour
Journal:  Haematologica       Date:  2017-11-23       Impact factor: 9.941

8.  Use of Eltrombopag in Improving Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Samip Master; Ashish Dwary; Richard Mansour; Glenn M Mills; Nebu Koshy
Journal:  Case Rep Oncol       Date:  2018-03-27

9.  Developments in the production of platelets from stem cells (Review).

Authors:  Jie Yang; Jianfeng Luan; Yanfei Shen; Baoan Chen
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

10.  The Effectiveness of Rapamycin Combined with Eltrombopag in Murine Models of Immune-Mediated Bone Marrow Failure.

Authors:  Shaoxue Ding; Xiaowei Liang; Tian Zhang; Rong Fu
Journal:  J Immunol Res       Date:  2020-10-17       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.